← All companies
Dyne Therapeutics, Inc.
DYN - CIK 0001818794
Market cap$2.92 B
Rank#1827
SEC filings710
The table below shows Dyne Therapeutics, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $100.89M | $97.22M | $99.24M | $106.45M | $92.80M | $62.26M |
| SG&A |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.